LILLY ELI & PHARMACEUTICAL DIV -- AM0766 CEFAZOLIN SODIUM
=======================================================
Material Safety Data Sheet
=======================================================
MSDS Num: BXKSQ
MSDS NAME: AM0766 CEFAZOLIN SODIUM
Responsible Party
Name: LILLY ELI & CO PHARMACEUTICAL DIV
Address: 307 E MCCARTY ST
City: INDIANAPOLIS IN 48285-5000
Info Phone: 317-276-2000/317-276-3494
Emergency Phone Number: 317-276-2000/317-276-3494
Review Ind: Y
Published: Y
=======================================================
Preparer Co. when other than Responsible Party Co.
=======================================================
Assigned Ind: Y
Name: LILLY ELI & CO PHARMACEUTICAL DIV
Address: LILLY CORPORATE CENTER
City: INDIANAPOLIS IN 46285
=======================================================
Contractor Summary
=======================================================
Name: LILLY ELI & CO PHARMACEUTICAL DIV
Address: LILLY CORPORATE CENTER
City: INDIANAPOLIS IN 46285
Phone: 317-276-2000
Name: LILLY ELI AND CO PHARMACEUTICAL DIV
Address: LILLY CORPORATE CENTER
City: INDIANAPOLIS IN 46285
Phone: 317-276-2000
=======================================================
Ingredients
=======================================================
Cas: 27164-46-1
RTECS #: XI0390000
Name: CEFAZOLIN SODIUM, BIAZOLINA, CEFAMEZIN
=======================================================
Health Hazards Data
=======================================================
Route Of Entry Inds - Inhalation: YES
Skin: NO
Ingestion: NO
Carcinogenicity Inds - NTP: NO
IARC: NO
OSHA: NO
Effects of Exposure: ALLERGIC REACTIONS HAVE BEEN REPORTED, WHICH MAY INCLUDE
EYE IRRITATION.
Explanation Of Carcinogenicity: NONE
Signs And Symptions Of Overexposure: RASH, NASAL CONGESTION, COUGH, DRY THROAT,
GASTROINTESTINAL UPSET, IRRITATION, ANAPHYLACTIC SHOCK.
Medical Cond Aggravated By Exposure: PENICILLIN/CEPHALOSPORIN HYPERSENSITIVITY.
First Aid: EYES: FLUSH W/PLENTY OF WATER. SKIN: WASH W/PLENTY OF SOAP &
WATER. INHALATION: MOVE TO FRESH AIR. IF NOT BREATHING, PROIDE CPR IF
NECESSARY. INGESTION: DON'T INDUCE VOMITING. ADMINISTER ACTIVATED CHA RCOAL
(6-8 HEAPING TEASPOONFULS) W/TWO TO THREE GLASSES OF WATER. DON'T GIVE
ANYTHING BY MOUTH IF UNCONSCIOUS. OBTAIN MEDICAL ATTENTION IN ALL CASES.
=======================================================
Handling and Disposal
=======================================================
Spill Release Procedures: CONTAIN DRY MATERIAL BY SWEEPING UP/VACUUMING USING A
DUST COLLECTION FILTER. BE AWARE OF DUST EXPLOSION WHEN USING ELECTRICAL
EQUIPMENT. WEAR PROTECTIVE EQUIPMENT, INCLUDING EYE PROTECTION, TO AVOID
EXPOSURE.
Waste Disposal Methods: DISPOSE OF ANY CLEANUP MATERIALS & WASTE RESIDUE IN
ACCORDANCE W/LOCAL, STATE & FEDERAL REGULATIONS.
Handling And Storage Precautions: UNDER NORMAL USE & HANDLING CONDITIONS,
NO PROTECTIVE EQUIPMENT IS REQUIRED.
=======================================================
Fire and Explosion Hazard Information
=======================================================
Extinguishing Media: WATER, CO2, DRY CHEMICAL, FOAM/HALON
Unusual Fire/Explosion Hazard: AS A FINELY DIVIDED MATERIAL, MAY FORM EXPLOSIVE
DUST MIXTURES IN AIR WHICH COULD EXPLODE IF SUBJECTED TO A SOURCE OF
IGNITION.
=======================================================
Control Measures
=======================================================
Respiratory Protection: USE AN APPROVED RESPIRATOR. IN PRODUCTION,
AIRLINE-SUPPLIED, HOOD-TYPE RESPIRATORS ARE PREFERRED.
Ventilation: LABORATORY FUME HOOD/LOCAL EXHAUST
Protective Gloves: CHEMICAL RESISTANT
Eye Protection: CHEMICAL GOGGLES/FACE SHIELD
Other Protective Equipment: CHEMICAL RESISTANT CLOTHING, SAFETY GLASSES
Work Hygienic Practices: REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE REUSE.
WASH THOROUGHLY AFTER HANDLING.
Supplemental Safety and Health: PH (10% SOLUTION): 4.5-6.
=======================================================
Physical/Chemical Properties
=======================================================
PH: (SUPP)
Solubility in Water: COMPLETE
Appearance and Odor: WHITE TO OFF-WHITE CRYSTALLINE POWDER W/NO ODOR
=======================================================
Reactivity Data
=======================================================
Stability Indicator: YES
Stability Condition To Avoid: HEAT
Materials To Avoid: STRONG OXIDIZING AGENTS
Hazardous Decomposition Products: TOXIC FUMES WHEN HEATED
Hazardous Polymerization Indicator: NO
=======================================================
Toxicological Information
=======================================================
=======================================================
Ecological Information
=======================================================
=======================================================
MSDS Transport Information
=======================================================
=======================================================
Regulatory Information
=======================================================
=======================================================
Other Information
=======================================================
=======================================================
HAZCOM Label
=======================================================
MSDS NAME: AM0766 CEFAZOLIN SODIUM
Assigned IND: Y
Company: LILLY ELI & CO PHARMACEUTICAL DIV
Street: LILLY CORPORATE CENTER
City: INDIANAPOLIS IN
Zipcode: 46285
Health Emergency Phone: 317-276-2000/317-276-3494
Label Required IND: Y
Date Of Label Review: 12/16/1998
Status Code: C
Label Date: 12/16/1998
Origination Code: G
Hazard And Precautions: ALLERGIC REACTIONS HAVE BEEN REPORTED, WHICH MAY
INCLUDE EYE IRRITATION.
RASH, NASAL CONGESTION, COUGH, DRY THROAT, GASTR
OINTESTINAL UPSET, IRRITATION, ANAPHYLACTIC SHOCK.
=======================================================
Disclaimer (provided with this information by the compiling agencies): This
information is formulated for use by elements of the Department of Defense.
The United States of America in no manner whatsoever expressly or implied
warrants, states, or intends said information to have any application, use or
viability by or to any person or persons outside the Department of Defense
nor any person or persons contracting with any instrumentality of the United
States of America and disclaims all liability for such use. Any person
utilizing this instruction who is not a military or civilian employee of the
United States of America should seek competent professional advice to verify
and assume responsibility for the suitability of this information to their
particular situation regardless of similarity to a corresponding Department
of Defense or other government situation.
*** END OF RECORD *** |
|
|